Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3D (APOBEC3D)

Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3D (APOBEC3D) is a member of the APOBEC3 subfamily of cytidine deaminases found in humans. It catalyzes the deamination of cytidine residues in single-stranded DNA, converting cytidine (C) to uracil (U), which results in C→T (or G→A on the complementary strand) mutations[1][2][3][4]. This molecular activity is crucial for the innate immune response against viruses, particularly retroviruses such as HIV. APOBEC3D operates primarily in immune centers and peripheral blood cells and may have both cytoplasmic and nuclear localization depending on splice variants[2]. While APOBEC3D plays a protective antiviral role, its ability to induce genomic DNA mutations and deletions can pose genotoxic risks and potentially contribute to cancer mutagenesis, though this is less documented compared to other APOBEC family members[2][4]. APOBEC3D shares core structural features with other APOBEC proteins, including a conserved zinc-dependent cytidine deaminase domain, and can bind single-stranded DNA and RNA through basic and aromatic residues that stabilize nucleic acid interactions[1]. Alternative splicing can give rise to multiple functional variants with distinct subcellular localizations and DNA mutator activities[2].

Other names

DNA dC->dU-editing enzyme APOBEC-3DAPOBEC3DEA3DA3DEARP6APOBEC3E (note: “APOBEC3E” is sometimes used synonymously, but technically corresponds to a pseudogene for this family[1][3])

For theoretical inhibitors: blockade of cytidine deaminase activity (prevent C-to-U mutations in DNA/RNA)[2]. For function: triggers antiviral response by inducing hypermutation in viral DNA during replication; restricts viral replication by mutagenesis and can induce somatic mutations in host DNA[1][2].